This Tgfbr2 G357W mutant strain recapitulates vascular and skeletal features of Loeys-Dietz Syndrome (LDS).
Harry Dietz, Johns Hopkins Medical Institute
Genetic Background | Generation |
---|---|
|
Allele Type | Gene Symbol | Gene Name |
---|---|---|
Targeted | Tgfbr2 | transforming growth factor, beta receptor II |
Loeys-Dietz Syndrome (LDS) is a connective tissue disorder that is characterized by a high risk for aneurysm and dissection throughout the arterial tree and phenotypically resembles Marfan Syndrome. LDS is caused by heterozygous missense mutations in either TGF receptor gene (TGFBR1 or TGFBR2).
This targeted mutant strain carries an G357W missense mutation associated with LDS in the mouse Tgfbr2 (transforming growth factor, beta receptor II) gene. Mutant and wildtype alleles are expressed approximately equally in the aortic walls of heterozygotes. Heterozygous mice develop progressive aortic root aneurysm, as well as elongation and tortuosity of the aortic arch and coronary arteries. A subtle but significant deviation from the wildtype condition is detectable at 4 weeks of age, and becomes highly reproducible and dramatic at 24 weeks. At 24 weeks of age, elastic fiber fragmentation is detectable in the aortic roots of these knockin mice. The aortic wall also shows progressive thickening with excessive collagen deposition. Approximately 10-15% of heterozygotes may die by 180 days of age due to aortic dissection. Hemothorax or hemopericardium is observable in approximately 60% of deaths. These mice also develop skeletal manifestations associated with LDS, such as kyphosis, overgrowth of the ribs and craniosynostosis.
Site-directed mutagenesis was performed to substitute glycine 357 with tryptophan (GGC->TGG; guanine to thymine and cytosine to guanine at nucleotides 1069 and 1071 respectively) in exon 4 of the targeted gene. A loxP-flanked neomycin selection cassette was placed in intron 3. Linearized targeting vector was introduced to 129S6/SvEvTac-derived embryonic stem (ES) cells. Chimeric offspring were mated to C57BL/6J. The loxP-flanked neomycin cassette was removed by mating animals with a CAG-Cre strain. Animals were backcrossed to 129S6/SvEvTac for at least 10 generations by the donating lab.
Allele Name | targeted mutation 1.1, Harry C Dietz |
---|---|
Allele Type | Targeted |
Allele Synonym(s) | Tgfbr2G357W |
Gene Symbol and Name | Tgfbr2, transforming growth factor, beta receptor II |
Gene Synonym(s) | |
Strain of Origin | 129S6/SvEvTac |
Chromosome | 9 |
Molecular Note | Site-directed mutagenesis was performed to substitute glycine 358 with tryptophan (GGC->TGG; guanine to thymine and cytosine to guanine at nucleotides 1069 and 1071 respectively) in exon 4 of the targeted gene. A loxP-flanked neomycin selection cassette was placed in intron 3. Cre-mediated recombination removed the floxed neo cassette. |
Heterozygotes are fertile, but show reduced viability. Approximately 10-15% of heterozygotes may die by 180 days of age due to aortic dissection. Homozygotes are not viable.
When using the 129S(Cg)-Tgfbr2tm1.1Hcd/J mouse strain in a publication, please cite the originating article(s) and include JAX stock #024634 in your Materials and Methods section.
Facility Barrier Level Descriptions
Service/Product | Description | Price |
---|---|---|
Heterozygous or Wilt type for Tgfbr2<tm1.1Hcd> |
Frozen Mouse Embryo | 129S(Cg)-Tgfbr2<tm1.1Hcd>/J Frozen Embryo | $2595.00 |
Frozen Mouse Embryo | 129S(Cg)-Tgfbr2<tm1.1Hcd>/J Frozen Embryo | $2595.00 |
Frozen Mouse Embryo | 129S(Cg)-Tgfbr2<tm1.1Hcd>/J Frozen Embryo | $3373.50 |
Frozen Mouse Embryo | 129S(Cg)-Tgfbr2<tm1.1Hcd>/J Frozen Embryo | $3373.50 |
Terms are granted by individual review and stated on the customer invoice(s) and account statement. These transactions are payable in U.S. currency within the granted terms. Payment for services, products, shipping containers, and shipping costs that are rendered are expected within the payment terms indicated on the invoice or stated by contract. Invoices and account balances in arrears of stated terms may result in The Jackson Laboratory pursuing collection activities including but not limited to outside agencies and court filings.
The Jackson Laboratory has rigorous genetic quality control and mutant gene genotyping programs to ensure the genetic background of JAX® Mice strains as well as the genotypes of strains with identified molecular mutations. JAX® Mice strains are only made available to researchers after meeting our standards. However, the phenotype of each strain may not be fully characterized and/or captured in the strain data sheets. Therefore, we cannot guarantee a strain's phenotype will meet all expectations. To ensure that JAX® Mice will meet the needs of individual research projects or when requesting a strain that is new to your research, we suggest ordering and performing tests on a small number of mice to determine suitability for your particular project. We do not guarantee breeding performance and therefore suggest that investigators order more than one breeding pair to avoid delays in their research.
What information were you hoping to find through your search?
How easy was it to find what you were looking for?
We may wish to follow up with you. Enter your email if you are happy for us to connect and reachout to you with more questions.
Please Enter a Valid Email Address
Thank you for sharing your feedback! We are working on improving the JAX Mice search. Come back soon for exciting changes.